Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced-Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High-Risk AML and MDS

Dusan Prevalsek, MD, Susanne Fritsch, MD, Max Hubmann, MD, Nicole Engel, MD, Anna-Katharina Zoellner, MD, Thomas Köhnke, MD, Veit Leonhard Bücklein, MD, Christoph Schulz, MD, Friederike Mumm, MD, Christina Theresa Rieger, MD, Georg Ledderose, MD, Hans-Joachim Stemmler, MD, Karsten Spiekermann, MD, Wolfgang Hiddemann, MD, Andreas Hausmann, MD, Johanna Tischer, MD

Blood (2015) 126 (23): 4318.

https://doi.org/10.1182/blood.V126.23.4318.4318

Published: 2015

Journal Articles

Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial

Daniel Wolff, MD, Philipp Y. Herzberg, PhD, Steven Z. Pavletic, MD, Pia Heussner, MD, Friederike Mumm, MD, Christina Balsiger, MD, Inken Hilgendorf, MD, Philipp Hemmati, MD, Ernst Holler, MD, PhD, Hildegard T Greinix, MD, Sandra A. Mitchell, PhD

Blood (2013) 122 (21): 2073.

https://doi.org/10.1182/blood.V122.21.2073.2073

Published: 2013

Journal Articles

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Daniel Wolff, Philipp Herzberg, Pia Heussner, Friederike Mumm, Inken Hilgendorf, MD, Stephanie von Harsdorf, MD, Philipp Hemmati, Armin Gerbitz, MD, Michael Schmitt, Ernst Holler, PhD, Hildegard Greinix

Blood (2009) 114 (22): 204.

https://doi.org/10.1182/blood.V114.22.204.204

Published: 2009

Journal Articles

Severity of Chronic Gvhd and Personality Determines Quality of Life and the Activity Profile: Results of a Prospective German Multicenter Validation Trial

Daniel Wolff, MD, Philipp Herzberg, Pia Heussner, MD, Friederike Mumm, MD, Inken Hilgendorf, MD, Stephanie von Harsdorf, MD, Armin Gerbitz, MD, Hildegard T. Greinix, MD, Joachim Hahn, MD, Christian Junghanss, MD, Ernst Holler, PhD

Blood (2008) 112 (11): 742.

https://doi.org/10.1182/blood.V112.11.742.742

Published: 2008

Journal Articles

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Daniel Wolff, MD, Philipp Y. Herzberg, Pia Heussner, MD, Friederike Mumm, MD, Stephanie von Harsdorf, MD, Katrin Rieger, MD, Hildegard Greinix, Joachim Hahn, MD, Ernst Holler, Mathias Freund

Blood (2007) 110 (11): 42.

https://doi.org/10.1182/blood.V110.11.42.42

Published: 2007

NARROW

Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced-Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High-Risk AML and MDS

Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Severity of Chronic Gvhd and Personality Determines Quality of Life and the Activity Profile: Results of a Prospective German Multicenter Validation Trial

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Email alerts

ASH Publications

American Society of Hematology

Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced-Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High-Risk AML and MDS

Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Severity of Chronic Gvhd and Personality Determines Quality of Life and the Activity Profile: Results of a Prospective German Multicenter Validation Trial

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only